
    
      Inclusion criteria:

        1. Male or non-pregnant females age 16 to 65 years inclusive.

        2. Written informed consent obtained from patient or parents/guardian.

        3. Patients with SLE fulfilling American Rheumatism Association criteria and SLEDAI score>8
           or BILAG score A/B.

        4. Patients with newly diagnosed World Health Organization (WHO) Class III or IV Lupus
           Nephritis.
    
  